Revolutionizing pharmaceutical development

by Lilien CheminformaticsUniversity of Toronto, December 2009SynPlan@gmail.com

1

University of Toronto, December 2009

Chemists use pen & paper to generate reaction plans for target molecule.

...over 100 million chemical substances and sequences! 2

Automate Planning

Reduce scale-up time from 2 yrs to 2 months

Extended patent protection

Discover new reaction pathways.

University of Toronto, December 2009 3

University of Toronto, December 2009 4Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009

BUSINESS MODEL CANVASInfrastructureInfrastructure CustomerCustomer

FinanceFinance

University of Toronto, December 2009 4

InfrastructureInfrastructure

Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009

BUSINESS MODEL CANVAS

Key ActivitiesPartner Network

Key Resources

R&D

Experts in chemistry & technology.

Academia

Reaction DB

Education

& Training

Publishing Companies

CustomerCustomer

FinanceFinance

University of Toronto, December 2009 4

CustomerCustomerInfrastructureInfrastructure

Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009

BUSINESS MODEL CANVAS

Key ActivitiesPartner Network

Key Resources

R&D

Experts in chemistry & technology.

Academia

Reaction DB

Education

& Training

Publishing Companies

Pharmaceutical companies

Distribution Channel

Training, Support

Reaction DB updates

Website with

cd/dvds of products

Networking within

Universities

FinanceFinance

FinanceFinance

University of Toronto, December 2009 4

CustomerCustomerInfrastructureInfrastructure

Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009

BUSINESS MODEL CANVAS

Key ActivitiesPartner Network

Key Resources

R&D

Experts in chemistry & technology.

Academia

Reaction DB

Education

& Training

Publishing Companies

Pharmaceutical companies

Distribution Channel

Training, Support

Reaction DB updates

Website with

cd/dvds of products

Networking within

Universities

Cost Structure Revenue Streams

Yearly Licensing

ModelSupport

Maintenance

Staff

R&D

Marketing

University of Toronto, December 2009 5

Completeness

ARChem

Theresa

SynChem

LHASA

University of Toronto, December 2009 6

Expertise Over 10 years of research

Partners Close relations industry

contacts

Opportunity Increasing cost Decreased drug approval

University of Toronto, December 2009

Peter Park, CEO

Brian Keng, CFO

Dejana Bajic, VP Sales and Marketing

Maryah Safi, VP Product Development

Amanda Manarin, Sales and Finance7

University of Toronto, December 2009 8

Total Operating Costs Total Revenue

Net Earnings

University of Toronto, December 2009

Invest $1.2 million: Alpha release of product Covers cash flow for first year Establish contacts with phamas

9